Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
7-2
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
advertisement
Classification List
1 General aspects
0
1.1
Epidemiology
3
1.2
Population genetics
1
1.3
Pathogenesis
3
1.4
Quality of life
4
1.5
Glaucomas as cause of blindness
2
1.6
Prevention and screening
4
2
Anatomical structures in glaucoma
1
2.1
Conjunctiva
1
2.2
Cornea
8
2.3
Sclera
1
2.4 Anterior chamber angle
0
2.5 Meshwork
0
2.5.1
Trabecular meshwork
12
2.5.2
Schlemms canal
1
2.5.3 Scleral outlet channels
0
2.6
Aqueous humor dynamics
3
2.6.1 Production
0
2.6.2
Outflow
1
2.6.2.1 Trabecular meshwork
0
2.6.2.2 Uveoscleral
0
2.6.3
Compostion
2
2.7 Episcleral veins and venous pressure
0
2.8 Iris
0
2.9
Ciliary body
3
2.10 Lens
0
2.11 Vitreous body
0
2.12 Choroid, peripapillary choroid, peripapillary atrophy
0
2.13
Retina and retinal nerve fibre layer
11
2.14
Optic disc
5
2.15
Optic nerve
2
2.16
Chiasma and retrochiasmal central nervous system
2
2.17 Stem cells
0
2.20 Other
0
3
Laboratory methods
8
3.1
Microscopy
2
3.2 Electron microscopy
0
3.3
Immunohistochemistry
13
3.4 Molecular genetics
0
3.4.1
Linkage studies
10
3.4.2
Gene studies
4
3.5 Molecular biology incl. SiRNA
0
3.6
Cellular biology
4
3.7 Biochemistry
0
3.8
Pharmacology
1
3.9
Pathophysiology
1
3.10
Immunobiology
2
3.11 Pharmacogenetics
0
3.12 Proteomics
0
3.13 In vivo imaging
0
3.13.1 Laser Scanning
0
3.13.1.1 Confocal Scanning Laser Ophthalmoscopy
0
3.13.1.2 Confocal Scanning Laser Polarimetry
0
3.13.2 Optical Coherence Tomography
0
3.13.2.1 Anterior Segment
0
3.13.2.2 Posterior Segment
0
3.13.3 RGC Imaging
0
3.13.4 Other
0
3.20
Other
1
4 Tissue culture of ocular cells
0
5
Experimental glaucoma; animal models
29
5.1 Rodent
0
5.2 Primates
0
5.3 Other
0
6 Clinical examination methods
0
6.1
Intraocular pressure measurement; factors affecting IOP
25
6.1.1 Devices, techniques
0
6.1.2 Fluctuation, circadian rhythms
0
6.1.3 Factors affecting IOP
0
6.2
Tonography, aqueous flow measurement (see also 2.6)
2
6.3 Biomicroscopy (slitlamp)
0
6.3.1 Anterior segment
0
6.3.2 Posterior segment
0
6.4
Gonioscopy
4
6.5 Ophthalmoscopy
0
6.6 Visual field examination and other visual function tests
0
6.6.1
Conventional manual
1
6.6.2
Automated
4
6.6.3
Special methods (e.g. color, contrast, SWAP etc.)
12
6.7
Electro-ophthalmodiagnosis
3
6.8 Photography
0
6.8.1 Anterior segment
0
6.8.2
Posterior segment
3
6.9 Computerized image analysis
0
6.9.1
Laser scanning
21
6.9.1.1 Confocal Scanning Laser Ophthalmoscopy
0
6.9.1.2 Confocal Scanning Laser Polarimetry
0
6.9.2
Optical coherence tomography
12
6.9.2.1 Anterior
0
6.9.2.2 Posterior
0
6.9.5 Other
0
6.10 Fluorescein (ICG) angiography
0
6.10.1 Anterior segment
0
6.10.2
Posterior segment
1
6.11
Bloodflow measurements
8
6.12
Ultrasonography and ultrasound biomicroscopy
5
6.13 Provocative tests
0
6.19
Telemedicine
1
6.20
Progression
5
6.30
Other
1
8 Refractive errors in relation to glaucoma
0
8.1
Myopia
2
8.2 Hypermetropia
0
8.3 Contact lenses
0
8.4
Refractive surgical procedures
7
8.5 Other
0
9 Clinical forms of glaucomas
0
9.1
Developmental glaucomas
2
9.1.1 Congenital glaucoma, Buphthalmos
0
9.1.2 Juvenile glaucoma
0
9.1.3
Syndromes of Axenfeld, Rieger, Peters, aniridia
6
9.1.4
Other
1
9.2 Primary open angle glaucomas
0
9.2.1
Ocular hypertension
3
9.2.2
Other risk factors for glaucoma
5
9.2.3 Open angle glaucoma with elevated IOP
0
9.2.4
Normal pressure glaucoma
4
9.3
Primary angle closure glaucomas
1
9.3.1
Acute primary angle closure glaucoma (pupillary block)
1
9.3.2
Chronic primary angle closure glaucoma (pupillary block)
2
9.3.3
Plateau iris syndrome
1
9.3.4 Primary angle closure suspect
0
9.3.5 Primary angle closure
0
9.3.10
Other
1
9.4 Glaucomas associated with other ocular and systemic disorders
0
9.4.1 Steroid-induced glaucoma
0
9.4.2 Glaucomas associated with disorders of the cornea, conjunctiva, sclera
0
9.4.2.1 Iridocorneal endothelial syndrome (ICE, incl. irisatrophy)
0
9.4.2.2 Posterior polymorphous dystrophy
0
9.4.2.3 Fuchs' endothelial dystrophy
0
9.4.2.5 Other
0
9.4.3 Glaucomas associated with disorders of the iris and ciliary body
0
9.4.3.1
Pigmentary glaucoma
2
9.4.3.5 Other
0
9.4.4 Glaucomas associated with disorders of the lens
0
9.4.4.1
Exfoliation syndrome
7
9.4.4.2
Glaucomas associated with cataracts
1
9.4.4.3 Glaucomas associated with lens dislocation
0
9.4.4.5 Other
0
9.4.5 Glaucomas associated with disorders of the retina, choroid and vitreous
0
9.4.5.1
Neovascular glaucoma
2
9.4.5.5 Other
0
9.4.6
Glaucomas associated with inflammation, uveitis
5
9.4.7
Glaucomas associated with ocular trauma
1
9.4.8 Glaucomas associated with intraocular tumors
0
9.4.9 Glaucomas associated with elevated episcleral venous pressure
0
9.4.10 Glaucomas associated with hemorrhage
0
9.4.11 Glaucomas following intraocular surgery
0
9.4.11.1
Ciliary block (malignant) glaucoma
1
9.4.11.2
Glaucomas in aphakia and pseudophakia
1
9.4.11.3 Epithelial, fibrous, and endothelial proliferation
0
9.4.11.4 Glaucomas associated with corneal surgery
0
9.4.11.5
Glaucomas associated with vitreoretinal surgery
2
9.4.15
Glaucoma in relation to systemic disease
5
9.4.20 Other
0
10
Differential diagnosis e.g. anterior and posterior ischemic optic neuropathy
6
11 Medical treatment
0
11.1
General management, indication
8
11.2
Cholinergic drugs
1
11.3 Adrenergic drugs
0
11.3.1 Epinephrine
0
11.3.2 Thymoxamine, dapiprazole
0
11.3.3 Apraclonidine, brimonidine
0
11.3.4
Betablocker
12
11.3.5 Other
0
11.4
Prostaglandins
31
11.5 Carbonic anhydrase inhibitors
0
11.5.1 Systemic
0
11.5.2
Topical
5
11.6 Osmotic treatment
0
11.7
Treatment of bloodflow
3
11.8
Neuroprotection
1
11.9 Gene therapy
0
11.13 Combination therapy
0
11.13.1 Betablocker and pilocarpine
0
11.13.2 Betablocker and carbon anhydrase inhibitor
0
11.13.3 Betablocker and brimonidine
0
11.13.4 Betablocker and prostaglandin
0
11.13.5 Other
0
11.14
Investigational drugs; pharmacological experiments
15
11.15
Other drugs in relation to glaucoma
4
11.16
Vehicles, delivery systems, pharmacokinetics, formulation
1
11.17
Cooperation with medical therapy e.g. persistency, compliance, adherence
3
11.20
Other
1
12 Surgical treatment
0
12.1
General management, indication
4
12.2
Laser iridotomy
3
12.3 Laser iridoplasty
0
12.4
Laser trabeculoplasty and other laser treatment of the angle
2
12.7 Surgical iridectomy
0
12.8 Filtering surgery
0
12.8.1
Without tube implant
9
12.8.2
With tube implant or other drainage devices
12
12.8.3
Non-perforating
6
12.8.4 Using laser
0
12.8.5 Other
0
12.8.10
Woundhealing antifibrosis
10
12.8.11
Complications, endophthalmitis
8
12.9
Trabeculotomy, goniotomy
1
12.10
Cyclodestruction
3
12.11 Cyclodialysis
0
12.12 Cataract extraction
0
12.12.1 Intracapsular
0
12.12.2 Extracapsular
0
12.12.3
Phacoemulsification
12
12.14 Combined cataract extraction and glaucoma surgery
0
12.14.1 Intracapsular
0
12.14.2
Extracapsular
1
12.14.3
Phacoemulsification
7
12.15 Capsulotomy
0
12.16 Vitrectomy
0
12.17 Anesthesia
0
12.20
Other
6
13 Therapeutic prognosis and outcome
0
13.1 Prognostic factors
0
13.2 Outcome
0
13.2.1 IOP
0
13.2.2 Visual field
0
13.2.2.1 Progression
0
13.2.2.2 Improvement
0
13.2.3 Other
0
14
Costing studies; pharmacoeconomics
5
15
Miscellaneous
10
Issue
7-2
Table of Contents
Editor's Selection
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement